Back to funds

Tetragon Partners GP Ltd

Updated 6 days ago

Managed by Tetragon Partners Gp Ltd • Latest filing Q3 2026

Portfolio value
$766M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
98.9%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$474.3M
Q1 2026$515.1M
Q2 2026$635.1M
Q3 2026$766M

Top holdings

41 positions as of Q3 2026

View filing
P

UIPATH INC

Value
$308.2M
Shares
24.00M
% Port
40.23%
P

UIPATH INC

Value
$67.7M
Shares
5.27M
% Port
8.83%
P

UIPATH INC

Value
$41.5M
Shares
3.23M
% Port
5.42%
S

SILENCE THERAPEUTICS PLC

Value
$26.6M
Shares
2.44M
% Port
3.48%
P

Pharvaris Nv

Value
$26.6M
Shares
838.2K
% Port
3.47%
K

KOLIBRI GLOBAL ENERGY INC

Value
$25.7M
Shares
4.15M
% Port
3.35%
I

IONIS PHARMACEUTICALS INC

Value
$19.7M
Shares
440.9K
% Port
2.57%
A

AUTOLUS THERAPEUTICS LTD

Value
$18.4M
Shares
9.50M
% Port
2.41%
A

ARROWHEAD PHARMACEUTICALS IN

Value
$17.3M
Shares
264.0K
% Port
2.26%
K

KOLIBRI GLOBAL ENERGY INC

Value
$16.6M
Shares
2.68M
% Port
2.16%
L

LYFT INC

Value
$15M
Shares
1.00M
% Port
1.96%
W

WORKIVA INC

Value
$15M
Shares
225.0K
% Port
1.96%
M

MBX BIOSCIENCES INC

Value
$12.9M
Shares
220.6K
% Port
1.69%
D

DEFINIUM THERAPEUTICS INC

Value
$11.8M
Shares
310.9K
% Port
1.54%
C

SPRINKLR INC

Value
$10.9M
Shares
2.20M
% Port
1.42%
C

CELLDEX THERAPEUTICS INC NEW

Value
$9.6M
Shares
295.9K
% Port
1.25%
I

IMMUNOVANT INC

Value
$9.3M
Shares
275.2K
% Port
1.21%
H

HARMONY BIOSCIENCES HLDGS IN

Value
$8.9M
Shares
226.7K
% Port
1.16%
A

ALKAMI TECHNOLOGY INC

Value
$8.9M
Shares
650.0K
% Port
1.16%
A

Alkermes PLC

Value
$8.4M
Shares
206.8K
% Port
1.09%

Explore